Sleep-disordered breathing is highly prevalent in childhood obesity. Two recent cross-sectional studies have demonstrated an independent association between the severity of sleep-disordered breathing and the metabolic syndrome. A limited number of studies have also addressed the correlation between sleep-disordered breathing and insulin resistance, the core factor of the metabolic syndrome. Cross-sectional reports in modestly obese children are in favor of an association between sleep apnea and insulin resistance. However, these findings were not confirmed in studies of normal-weight children and of morbidly obese children. Only one out of three treatment studies before and after adenotonsillectomy confirmed the association between sleep apnea and insulin resistance, but only in obese children. Although statistical power issues and differences in patient characteristics might partially explain these contradicting results, the evidence to date is far from establishing a causal link between sleep-disordered breathing and insulin resistance. Longitudinal studies and randomized control trials are therefore warranted to investigate a possible causal link between sleep-disordered breathing and insulin resistance.
Introduction
The prevalence of childhood obesity has reached epidemic proportions worldwide and is still increasing. Obesity in children and adolescents is now recognized as a major medical and public health problem, because it affects nearly every major organ system. 1 Possible complications include insulin resistance, dyslipidemia and hypertension. 1 The clustering of these factors is also known as the metabolic syndrome. In the pediatric population, the overall prevalence of the metabolic syndrome is estimated at 4%, but the prevalence of this syndrome is 20-50% in overweight children. [2] [3] [4] Furthermore, the metabolic syndrome during childhood and/or adolescence is already associated with cardiovascular morbidity in early adulthood, [5] [6] [7] which stresses the importance of early prevention, diagnosis and treatment for obesity and its related conditions.
Although genetics, dietary habits and lack of physical activity mainly contribute to the onset of the metabolic syndrome, recent evidence suggests that other factors could in addition be involved in the onset of the metabolic syndrome. One of these factors could be sleep-disordered breathing. For a detailed overview of obesity as a risk factor for sleep-disordered breathing in children, a recent paper reviews the prevalence of sleep-disordered breathing in obese children and the role of adiposity and upper airway factors in the pathogenesis of sleep-disordered breathing in these children. 8 To summarize, obese children show an increased risk of developing all types of sleep-disordered breathing. First, primary snoring is considered a relatively more benign expression of abnormal upper airway resistance, 9 and various epidemiological studies have indicated that obese children exhibit an increased likelihood of snoring as compared with their normal-weight peers. 10, 11 Second, the main component of obstructive types of sleep-disordered breathing, that is obstructive sleep apnea syndrome (OSAS), is characterized by recurrent events of partial and/or complete upper airway obstruction, resulting in a disruption of normal ventilation and sleep. 12 Studies that have used polysomnography in hospital settings found frequencies of OSAS between 13 and 59% in obese children, depending on the definitions used for obesity and OSAS. 8 Finally, although limited data are available regarding the occurrence of central apneas as related to childhood obesity, two recent studies found an association between childhood obesity and central sleep apnea. 13, 14 The main consequence of the repetitive apneas and hypopneas during sleep is intermittent hypoxia, which is a potent trigger of oxidative stress and inflammation. 15 Indeed, several studies have documented increased markers of oxidative stress and inflammation in obese children who exhibit sleep apnea. [16] [17] [18] Other mechanisms by which sleep-disordered breathing may disturb metabolic control include increased sympathetic activity, 19 higher serum cortisol, 20 increased leptin levels 21 and impaired glucose tolerance and appetite regulation, resulting from secondary sleep debt. [22] [23] [24] Furthermore, intermittent hypoxia even in lean mice has been shown to induce insulin resistance. 25 In this review, we will provide a concise overview of the current evidence regarding the association between sleepdisordered breathing and the metabolic syndrome in children and adolescents. Furthermore, as insulin resistance is a core factor in the development of the metabolic syndrome and its associated abnormalities due to its influence on numerous markers and effectors of cardiovascular disease, 26 the interaction between sleep apnea and insulin resistance will also be reviewed.
Literature search
PubMed was searched for articles published in English before June 2008 using the following search criteria: ('obstructive sleep apnea' or 'sleep-disordered breathing' or 'sleep apnea'), ('children or adolescents') and ('metabolic syndrome' or 'insulin resistance syndrome' or 'insulin' or 'glucose' or 'insulin resistance'). Furthermore, all references in the selected articles were reviewed to identify additional published work.
Sleep-disordered breathing and the metabolic syndrome
Recently, our group published the first cross-sectional study on the relationship between sleep-disordered breathing and the metabolic syndrome in a clinical sample of overweight children. 27 Regardless of symptoms suggesting the presence of sleep apnea, all children were referred because of being overweight. The metabolic syndrome was defined based on the definition proposed by Cook et al.
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; that is, if three or more of the following were present, the patient was diagnosed with metabolic syndrome: (1) waist circumference X90th percentile adjusted for age and sex; (2) fasting glucose X110 mg per 100 ml; (3) fasting triglycerides X110 mg per 100 ml; (4) fasting high-density lipoproteins cholesterol p40 mg per 100 ml; (5) blood pressure X90th percentile adjusted for age and sex. In this study, a total of 104 subjects with a mean age of 11.1 ± 2.6 years were included. Of the subjects, 31% were overweight and 69% were obese. All subjects were nondiabetic. The metabolic syndrome was present in 37% of our subjects. Although the diagnosis of sleep-disordered breathing was not significantly associated with the presence of the metabolic syndrome, two markers of its severity were predictive of its presence, namely the mean saturation during sleep (odds ratio ¼ 0.54; 95% confidence interval ¼ 0.30-0.97) and the minimal saturation during sleep (odds ratio ¼ 0.89; 95% confidence interval ¼ 0.79-0.99), when controlling for gender, puberty and body mass index (BMI). The odds ratio for the mean saturation implies that each 1% increase in mean saturation during sleep was associated with a 50% reduction in the odds of presenting with versus without the metabolic syndrome.
Redline et al. 28 also cross-sectionally assessed the same association in a prospective cohort study of a slightly older population of adolescents who were recruited from the general community. The metabolic syndrome was defined according to the definitions by de Ferranti et al. 29 and by
Cook et al. 2 The average age of the participants was 13.7
, and approximately 25% of the subjects were overweight. The prevalence of the metabolic syndrome was 19%, and 46 out of the 52 adolescents with the metabolic syndrome were overweight or obese. After adjusting for age, race, sex and preterm status, children with sleep-disordered breathing, which was defined as more than five apneas and/or hypopneas per hour of sleep, exhibited 6.5 times higher odds of presenting with the metabolic syndrome as compared with children without sleep apnea. Furthermore, a highly significant linear association was observed between the metabolic syndrome and increasing levels of the apnea hypopnea index ( Figure 1 ). Furthermore, similar to the study by Verhulst et al., alternative measures of sleep-disordered breathing, including the apnea hypopnea index, the duration of desaturation, mean saturation and minimal saturation, were significant predictors of the metabolic syndrome. From these two reports we can conclude that the severity of sleep-disordered breathing is correlated to the metabolic syndrome in overweight children and adolescents. However, these cross-sectional studies do not necessarily imply a causal link. Therefore, we recommend the following research priorities:
1. More studies are warranted to confirm these findings in children of all age ranges. 2. Longitudinal studies are warranted to determine the future impact of sleep apnea on metabolic and cardiovascular morbidity. 3. In line with the recommendations given by Redline et al., 28 the interrelationship between childhood obesity, Sleep apnea and metabolic syndrome SL Verhulst et al metabolic syndrome and sleep apnea emphasizes the importance of weight management trials in these children. However, as weight management is often unsuccessful, further randomized control trials are required to assess the benefit of a specific treatment for sleep apnea (for example, adenotonsillectomy and continuous positive airway pressure (CPAP)) on current and future metabolic dysregulation in obese children and adolescents.
Sleep-disordered breathing and insulin resistance
Insulin resistance is probably the core factor for the metabolic syndrome, because of its influence on numerous markers and effectors of cardiovascular disease. 26 There are nine reports that have investigated the correlation between sleep-disordered breathing and surrogate markers of insulin resistance. The main details of these studies are presented in Table 1 . In seven of these reports, insulin resistance was assessed using fasting insulin, insulin-to-glucose ratio and/or the homeostasis model assessment or homeostasis model assessment (HOMA) index. 36 Insulin resistance is reflected by increased HOMA levels. Two other studies assessed insulin resistance using oral glucose tolerance tests, 27, 28 which can be considered an alternative method for studying glucose homeostasis. Unfortunately, no studies have used the insulin clamp technique, which is considered the gold standard for assessing insulin sensitivity. A direct comparison of these studies is complicated because of different inclusion criteria and different definitions of the principal outcome variable. de la Eva et al. 30 published the first study on sleep apnea and insulin resistance in a population of obese children who snore. Through multiple regression analysis, positive associations were found between the respiratory disturbance index, time spent below 90% oxygen saturation and fasting insulin levels. This analysis controlled for age and BMI. It can be noted that the respiratory disturbance index incorporated both obstructive and central events. Secondly, a negative association with the arousal index was also reported. However, this could be due to a statistical problem, namely multicollinearity, as all measures of the severity of sleepdisordered breathing were put into the same model. These associations with fasting insulin were confirmed by Li et al.
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and Redline et al., 28 both of whom found that a diagnosis of sleep-disordered breathing was associated with higher insulin concentrations. Flint et al. 23 studied 40 obese children. Of these children, 32 had OSAS. Subjects with OSAS had a significantly higher HOMA index than their peers without OSAS. No difference was observed in the BMI z-score between these two groups. However, sleep duration, not the apnea hypopnea index, was a significant correlate of HOMA levels in multiple regression analysis. Other than the study by Li et al., the study from our group is the only study to date that has also controlled for body fat distribution. 
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Although we could not document any correlation between sleep-disordered breathing and fasting indices of insulin resistance, we found that a lower mean oxygen saturation during sleep was associated with increased values for the area under the curve for glucose levels during an oral glucose tolerance test. This effect was independent of waist circumference. Waters et al. 35 used structural equation modeling to assess the interrelations between childhood obesity, OSAS, inflammation and metabolic dysfunction. The metabolic factor for this model comprises glucose, insulin and leptin. The structural equation model also indicated that spontaneous arousals and oxygen saturation were weakly although significantly associated with this metabolic variable. Dubern et al. 34 found a significant univariate correlation between the arousal index and the HOMA index in 54 severely obese children, although the significance was lost after controlling for age, gender, ethnicity and the Tanner stage. The authors suggested that hormonal influences are more important in the pathogenesis of insulin resistance than sleep-disordered breathing. However, another factor is clearly different in this study as compared with the previous studies of obese children. The study population in Dubern et al. comprises only morbidly obese children. In this case, morbid obesity was defined as a BMI z-score greater than 3. The impact of obesity on insulin resistance may possibly overcome the influence of sleep-disordered breathing in these subjects. The two other negative studies are characterized by a somewhat younger population, reflecting that the duration of sleep-disordered breathing and hormonal influences might influence metabolic dysregulation. 31, 32 Second, the fact that these studies are limited to or have included non-obese subjects could suggest that sleep-disordered breathing in young normal-weight children might not be severe enough to invoke insulin resistance in the absence of an obesity-related metabolic dysregulation. As a recommendation for further research, future cross-sectional reports should, therefore, not only control for the duration of obesity, hormonal influences and the degree of obesity but also should check for effect modification or interaction between the severity of sleep-disordered breathing and age, puberty and anthropometric measures. These issues clearly warrant more research on the association with an emphasis on longitudinal and treatment studies into the association between sleep apnea and insulin resistance in children and adolescents. Future reports from ongoing prospective cohort studies, including the Cleveland obese children who were all diagnosed with OSAS before and after adenotonsillectomy. Similar to the cross-sectional studies, the authors found that only fasting insulin and insulin/glucose ratio improved in the obese group after surgery. The main indicator of the change in insulin/glucose ratio was the observed decrease in the number of respiratory arousals (r ¼ 0.46; Po0.001). Obese children were also at risk of presenting with residual OSAS after surgery (that is, only 9 of the 37 obese children were considered cured after adenotonsillectomy). The obese children with resolved OSAS had a more marked improvement in insulin sensitivity (that is, the insulin/glucose ratio decreased from 0.27 ± 0.03 to 0.18±0.02; Po0.01) as compared with the obese group with residual OSAS (that is, the insulin/glucose ratio decreased from 0.30 ± 0.02 to 0.25 ± 0.02; Po0.05). Furthermore, the insulin/glucose ratio after surgery was significantly higher in the latter group (Po0.03). Finally, in a study of 58 Greek children with sleep-disordered breathing, which included 19 obese children, a significant increase was observed in fasting insulin and the HOMA index levels after adenotonsillectomy, whereas no change was observed in 17 control subjects. 40 This increase was possibly mediated by an increase in the BMI z-score after surgery. Second, no significant changes were observed in the insulin or HOMA index values when children with or without residual sleepdisordered breathing after adenotonsillectomy were divided into subgroups according to the presence of obesity. A number of hypotheses could explain these contradictory results. First, consider the issue of statistical power. Although the study by Apostolidou et al. 40 included a sample size calculation, it was based on C-reactive protein as outcome variable. Furthermore, in view of the cross-sectional studies stated above, the study population needs to be divided according to the presence of obesity as well as to the presence or absence of residual sleep-disordered breathing after adenotonsillectomy. A correct sample size calculation should acknowledge this issue. Second, the study group in Gozal et al. was slightly older than in the two other studies. This emphasizes the importance of studying children of all age ranges. Additional large treatment studies are thus urgently needed to confirm the association between sleepdisordered breathing and insulin resistance in obese children and adolescents. In the treatment study by Apostolidou et al., children gained weight after adenotonsillectomy. This possibly caused a significant increase in insulin levels, which again stresses the importance of weight loss trials that investigate the combined effects of weight loss on sleepdisordered breathing and insulin resistance. However, it can be noted that the success rate of a weight management intervention can be poor, and studies must consider the issue of long-term weight management in obese children. Therefore, we also recommend randomized controlled trials that address the additional beneficial effects of adenotonsillectomy or CPAP therapy in addition to weight management therapy on metabolic dysregulation. From a research perspective, CPAP therapy could be the most interesting option because one can assess immediate and short-term effects of the elimination of sleep apnea on metabolic markers. However, it can be noted that most children and adolescents with OSAS experience less excessive daytime sleepiness as compared with adults, which has been shown to be a predictor of CPAP adherence. 41 
Conclusion
Although cross-sectional studies and one intervention study have demonstrated an association between the severity of sleep-disordered breathing, the metabolic syndrome and insulin resistance in childhood obesity, a clear need exists for further studies that assess a causal link between these factors. From this perspective, we recommend the inception of longitudinal studies to examine the influence of pediatric sleep-disordered breathing on the development of cardiovascular and metabolic morbidity in early adulthood. Second, weight loss trials and randomized controlled trials using specific treatment for sleep-disordered breathing in addition to weight management are needed.
